Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,954,700
  • Shares Outstanding, K 670,000
  • Annual Sales, $ 901,940 K
  • Annual Income, $ -314,930 K
  • 60-Month Beta 1.98
  • Price/Sales 2.41
  • Price/Cash Flow N/A
  • Price/Book 1.81
Trade OPK with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.04
  • Number of Estimates 3
  • High Estimate 0.04
  • Low Estimate 0.04
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.88 +13.66%
on 12/29/20
4.78 -7.74%
on 01/15/21
-0.15 (-3.29%)
since 12/22/20
3-Month
3.02 +46.03%
on 11/09/20
4.92 -10.37%
on 12/04/20
+0.14 (+3.28%)
since 10/22/20
52-Week
1.12 +294.77%
on 04/03/20
6.47 -31.84%
on 07/21/20
+2.68 (+154.91%)
since 01/22/20

Most Recent Stories

More News
OPKO Health's (OPK) BioReference Extends Digital Health Access

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

HOLX : 75.70 (-0.29%)
OPK : 4.41 (+0.68%)
ATEC : 14.81 (+1.72%)
CMD : 79.72 (-0.35%)
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced , an in-home, fully integrated digital platform providing access to on-demand diagnostic...

OPK : 4.41 (+0.68%)
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q'20 Guidance

Sian Capital, LLC (together with its affiliates, "Sian" or "we"), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) ("OPKO" or the "Company"), today announced that it sent a letter to the Company's...

JPM : 133.79 (-0.77%)
OPK : 4.41 (+0.68%)
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know

OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.

OPK : 4.41 (+0.68%)
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39 Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be...

JPM : 133.79 (-0.77%)
OPK : 4.41 (+0.68%)
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout boroughs, with a positivity...

OPK : 4.41 (+0.68%)
OPKO Health's (OPK) BioReference Starts Fan Testing Program

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

MCK : 185.01 (+1.21%)
MMSI : 57.81 (+1.74%)
PDCO : 32.50 (+3.67%)
OPK : 4.41 (+0.68%)
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for somatrogon,...

PFE : 36.55 (+0.19%)
OPK : 4.41 (+0.68%)
Buffalo Bills and OPKO Health's BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

, /PRNewswire/ -- Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the...

OPK : 4.41 (+0.68%)
World Down Syndrome Market Insight, Epidemiology and Market Forecast Report 2017-2030 Featuring AC Immune, Annovis Bio, Alzheon, OPKO Health, & Aelis Farma

The "Down Syndrome - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

OPK : 4.41 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

3rd Resistance Point 4.59
2nd Resistance Point 4.51
1st Resistance Point 4.46
Last Price 4.41
1st Support Level 4.33
2nd Support Level 4.25
3rd Support Level 4.20

See More

52-Week High 6.47
Fibonacci 61.8% 4.43
Last Price 4.41
Fibonacci 50% 3.79
Fibonacci 38.2% 3.16
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar